307
Participants
Start Date
May 31, 2007
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
pregabalin
150 milligram (mg)/ day (double blind)
pregabalin
300 mg/day (double blind)
Placebo
Placebo
Pfizer Investigational Site, New York
Pfizer Investigational Site, Pittsburgh
Pfizer Investigational Site, Allentown
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, King of Prussia
Pfizer Investigational Site, Baltimore
Pfizer Investigational Site, Charlotte
Pfizer Investigational Site, Vero Beach
Pfizer Investigational Site, Tuscaloosa
Pfizer Investigational Site, Tuscaloosa
Pfizer Investigational Site, Northport
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Columbus
Pfizer Investigational Site, Upper Arlington
Pfizer Investigational Site, Chicago
Pfizer Investigational Site, Galesburg
Pfizer Investigational Site, Lafayette
Pfizer Investigational Site, New Iberia
Pfizer Investigational Site, Little Rock
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Houston
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Egg Harbor
Pfizer Investigational Site, Pomona
Pfizer Investigational Site, Voorhees Township
Pfizer Investigational Site, Pittsburgh
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY